Nilotinib Impurity 7
|
|
Nilotinib Impurity 7 속성
- 녹는점
- >245°C (dec.)
- 저장 조건
- Refrigerator
- 용해도
- DMSO(약간 용해됨), 메탄올(매우 소량, 가열)
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 옅은 노란색에서 옅은 베이지까지
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | |||||||||||||||||||||||||||||||||||
유해·위험 문구: |
|
|||||||||||||||||||||||||||||||||||
예방조치문구: |
|
Nilotinib Impurity 7 C화학적 특성, 용도, 생산
용도
N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]Benzamide, is an imurtiy of Nilotinib (N465300), that might be useful in treatment of chronic myelogenous leukemia.Nilotinib Impurity 7 준비 용품 및 원자재
원자재
준비 용품
Nilotinib Impurity 7 공급 업체
글로벌( 36)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11927 | 58 |
ShenZhen H&D Pharmaceutical Technology Co., LTD | +8613627253706 |
sale@hdimpurity.com | China | 1505 | 58 |
BOC Sciences | 1-631-485-4226; 16314854226 |
info@bocsci.com | United States | 14059 | 65 |
Taizhou Tongxin Bio-Tech Co., Ltd | 0523-18601685-898 18652728585 |
sales@allyrise.com | China | 2743 | 60 |
ChemStrong Scientific Co.,Ltd | 0755-66853366 13670046396 |
sales@chem-strong.com | China | 17982 | 56 |
Nanjing XiZe Biotechnology CO., Ltd. | 025-58362220 15250997978 |
1511893459@qq.com | China | 7715 | 55 |
Zhaoqing Wanwei New Material Technology Co., Ltd. | 0755-1328880-4488 13068786899 |
13288804488@163.com | China | 625 | 58 |
Xinxiang City Oran Biotechnology Co. Ltd. | 0373-6766851 18568539857 |
alchemic516@163.com | China | 66 | 58 |
TOSUN PHARM | 020-61855200 13326451905 |
2881290884@qq.com | China | 7481 | 58 |
Hubei Moco Chemical Co., Ltd. | 18627756402 |
3001051413@qq.com | China | 10009 | 58 |
Nilotinib Impurity 7 관련 검색:
NILOTINIB IMPURITY 11
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate
1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]-
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
Benzenamine, 3-(2-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-
Methyl 3-amino-4-methylbenzoate
Nilotinib Impurity 10
Nilotinib N-Oxide
Nilotinib genotoxic impurity 3
Nilotinib Impurity 1
Nilotinib Impurity 20
3-Amino-4-methylbenzoic acid
Nilotinib Impurity 28
Nilotinib impurity 3